Added to YB: 2025-11-28
Pitch date: 2025-09-29
GUTS [bullish]
Fractyl Health, Inc.
-69.23%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.
Market Cap
$64.2M
Pitch Price
$1.50
Price Target
13.00 (+2716%)
Dividend
N/A
EV/EBITDA
-0.56
P/E
-0.18
EV/Sales
16.2K
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
Fractyl Health, Inc. - $GUTS
GUTS: Post-GLP-1 weight maintenance solution via duodenal procedure. 3-mo sham-controlled data: DMR patients lost additional 2.5% weight vs 10% regain in sham (p=0.014). Addresses major unmet need - 75% stop GLP-1s within 2yrs, regain 70% weight lost. Pivotal trial reads 2H26.
Read full article (12 min)